Vascular endothelial growth factor A — Drug Target
All drugs that target Vascular endothelial growth factor A — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Vascular Endothelial Growth Factor Inhibitor · Vascular Endothelial Growth Factor Inhibitor [EPC]
Marketed (10)
- Vegf Trap · Regeneron · Vascular Endothelial Growth Factor Inhibitor · Oncology
- Vabysmo · Roche · Metabolic
Vabysmo works by blocking the activity of a protein called vascular endothelial growth factor A. - Avastin · Roche · Vascular Endothelial Growth Factor Inhibitor [EPC] · Oncology
Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors. - BYOOVIZ · SAMSUNG BIOEPIS CO LTD · Metabolic
- Avastin · Washington University School of Medicine · Oncology
- Beovu · Novartis Pharmaceuticals · Metabolic
- Lucentis · Santen Inc. · Metabolic
- Macugen · Valeant Pharms Llc · Ophthalmology
- Macugen · Bausch Health · Ophthalmology
- Beovu · Novartis · Metabolic
Beovu works by binding to vascular endothelial growth factor A (VEGF-A), preventing its interaction with its receptor and reducing vascular permeability and inflammation.